Walnut Creek, CA, April 15, 2015 — Insignia Capital Group today announced the acquisition of MNG Direct from DFW Capital Partners and the original Company founders. Terms of the transaction were not disclosed.
Based in Bensalem, PA, MNG Direct is a provider of technology-enabled multi-channel marketing solutions that allow pharmaceutical, biotechnology and medical device brands to effectively market their products to healthcare practitioners. The Company was created through the 2013 merger of MetaPharm, a provider of data-driven email and direct mail marketing services, and NexGen, a provider of online video and virtual meeting marketing services.
“We are thrilled about our new partnership with Insignia. We expect their strategic and operational expertise to be immensely valuable as we seek to accelerate our growth,” said Chris Wiltshire, President and CEO of MNG Direct. “We have built a diverse multi-channel marketing solution set to serve our clients’ growing needs. With Insignia’s help, we intend to further develop and integrate our offerings to deliver a true multi-channel solution that provides significant ROI to our clients.”
“We look forward to working with Chris and his team to continue to expand MNG Direct’s capabilities,” said Tony Broglio, a Partner at Insignia. “Reduced access to healthcare practitioners is driving pharmaceutical, biotechnology and medical device companies to spend more on multi-channel marketing services. We believe MNG Direct’s full-service offering and technology solutions position the Company at the forefront of the multi-channel marketing sector. We look forward to supporting management to further build upon the Company’s market position with the goal of producing a successful and rewarding outcome for MGN Direct’s clients, employees and shareholders.”
Lazard Middle Market LLC served as exclusive financial advisor and Dickstein Shapiro LLP served as legal counsel to the Company. Kirkland & Ellis LLP provided legal counsel to Insignia.
About MNG Direct
Based in Bensalem, PA, MNG Direct (fka metanexgen) is a provider of technology-enabled multi-channel marketing solutions that allow pharmaceutical, biotechnology and medical device brands to effectively market their products to healthcare practitioners. Insignia acquired the company in April 2015. www.MNGDirect.com.